Document is current
Any future updates will be listed below
-
Authors
Schneider, Melanie https://orcid.org/0000-0002-7085-6731
Radoux, Chris J.
Hercules, Andrew
Ochoa, David
Dunham, Ian https://orcid.org/0000-0003-2525-5598
Zalmas, Lykourgos-Panagiotis https://orcid.org/0000-0002-4317-7709
Hessler, Gerhard
Ruf, Sven
Shanmugasundaram, Veerabahu
Hann, Michael M.
Thomas, Pam J.
Queisser, Markus A. https://orcid.org/0000-0002-3368-3827
Benowitz, Andrew B.
Brown, Kris
Leach, Andrew R. https://orcid.org/0000-0001-8178-0253
- License Information
-
More Information
Article History
Accepted: 9 June 2021
First Online: 20 July 2021
Competing interests
: G.H., S.R., V.S., M.M.H., P.J.T., M.A.Q., A.B.B. and K.B. work for companies involved in the discovery of PROTAC compounds as part of their overall drug discovery efforts. The other authors declare no competing interests.
